Reported Earnings • Dec 02
First half 2025 earnings released: EPS: UK£0.012 (vs UK£0.003 in 1H 2024) First half 2025 results: EPS: UK£0.012 (up from UK£0.003 in 1H 2024). Revenue: UK£4.97m (up 30% from 1H 2024). Net income: UK£167.0k (up 288% from 1H 2024). Profit margin: 3.4% (up from 1.1% in 1H 2024). The increase in margin was driven by higher revenue. Over the last 3 years on average, earnings per share has increased by 6% per year but the company’s share price has fallen by 8% per year, which means it is significantly lagging earnings. Board Change • Nov 18
Less than half of directors are independent Following the recent departure of a director, there is only 1 independent director on the board. The company's board is composed of: 1 independent director. 6 non-independent directors. Senior Independent Non-Executive Director Charles Adam Sebag-Montefiore was the last independent director to join the board, commencing their role in 2014. The company's minority of independent directors is a risk according to the Simply Wall St Risk Model. Reported Earnings • Jul 26
Full year 2024 earnings released: EPS: UK£0.022 (vs UK£0.017 in FY 2023) Full year 2024 results: EPS: UK£0.022 (up from UK£0.017 in FY 2023). Revenue: UK£9.27m (up 2.3% from FY 2023). Net income: UK£300.0k (up 30% from FY 2023). Profit margin: 3.2% (up from 2.5% in FY 2023). The increase in margin was driven by higher revenue. Over the last 3 years on average, earnings per share has increased by 51% per year but the company’s share price has only increased by 6% per year, which means it is significantly lagging earnings growth. お知らせ • Jul 26
Scholium Group Plc, Annual General Meeting, Sep 26, 2024 Scholium Group Plc, Annual General Meeting, Sep 26, 2024. Location: 94 new bond street, w1s 1sj, london United Kingdom New Risk • Jun 17
New minor risk - Financial data availability The company's latest financial reports are more than 6 months old. Last reported fiscal period ended September 2023. This is considered a minor risk. If the company has not reported its earnings on time, it may have been delayed due to audit problems or it may be finding it difficult to reconcile its accounts. Currently, the following risks have been identified for the company: Major Risk Market cap is less than US$10m (UK£4.90m market cap, or US$6.21m). Minor Risks Latest financial reports are more than 6 months old (reported September 2023 fiscal period end). Profit margins are more than 30% lower than last year (0.9% net profit margin). Reported Earnings • Dec 03
First half 2024 earnings released: EPS: UK£0.003 (vs UK£0.014 in 1H 2023) First half 2024 results: EPS: UK£0.003 (down from UK£0.014 in 1H 2023). Revenue: UK£3.84m (down 14% from 1H 2023). Net income: UK£43.0k (down 78% from 1H 2023). Profit margin: 1.1% (down from 4.4% in 1H 2023). The decrease in margin was driven by lower revenue. Over the last 3 years on average, earnings per share has increased by 82% per year but the company’s share price has only increased by 1% per year, which means it is significantly lagging earnings growth. New Risk • Jul 29
New minor risk - Profit margin trend The company's profit margins are lower than last year and have reduced by more than 30%. Net profit margin: 2.5% Last year net profit margin: 6.1% This is considered a minor risk. A large drop in profit margin could indicate the company does not have strong competitive advantages or it is yet to establish itself and its core business. Even if it is a well established business, this may make it a much riskier investment than one that has a combination of proven competitive advantages and a stable or growing profit margin. Currently, the following risks have been identified for the company: Major Risk Market cap is less than US$10m (UK£5.10m market cap, or US$6.56m). Minor Risk Profit margins are more than 30% lower than last year (2.5% net profit margin). Reported Earnings • Jul 28
Full year 2023 earnings released: EPS: UK£0.017 (vs UK£0.036 in FY 2022) Full year 2023 results: EPS: UK£0.017 (down from UK£0.036 in FY 2022). Revenue: UK£9.06m (up 12% from FY 2022). Net income: UK£231.0k (down 53% from FY 2022). Profit margin: 2.5% (down from 6.1% in FY 2022). The decrease in margin was driven by higher expenses. Over the last 3 years on average, earnings per share has increased by 94% per year but the company’s share price has only increased by 4% per year, which means it is significantly lagging earnings growth. お知らせ • Jul 28
Scholium Group Plc, Annual General Meeting, Sep 26, 2023 Scholium Group Plc, Annual General Meeting, Sep 26, 2023, at 09:00 Coordinated Universal Time. Location: 106 New Bond Street London United Kingdom Board Change • Nov 16
Less than half of directors are independent Following the recent departure of a director, there is only 1 independent director on the board. The company's board is composed of: 1 independent director. 6 non-independent directors. Senior Independent Non-Executive Director Charles Adam Sebag-Montefiore was the last independent director to join the board, commencing their role in 2014. The company's minority of independent directors is a risk according to the Simply Wall St Risk Model. お知らせ • Aug 25
Scholium Group Plc, Annual General Meeting, Sep 28, 2022 Scholium Group Plc, Annual General Meeting, Sep 28, 2022, at 09:30 Coordinated Universal Time. Location: 106 New Bond Street London United Kingdom Reported Earnings • Aug 25
Full year 2022 earnings released: EPS: UK£0.036 (vs UK£0.032 loss in FY 2021) Full year 2022 results: EPS: UK£0.036 (up from UK£0.032 loss in FY 2021). Revenue: UK£8.13m (up 35% from FY 2021). Net income: UK£494.0k (up UK£931.0k from FY 2021). Profit margin: 6.1% (up from net loss in FY 2021). The move to profitability was driven by higher revenue. Over the last 3 years on average, earnings per share has remained flat whereas the company’s share price has increased by 2% per year. Board Change • Apr 27
Less than half of directors are independent Following the recent departure of a director, there is only 1 independent director on the board. The company's board is composed of: 1 independent director. 4 non-independent directors. Senior Independent Non-Executive Director Charles Adam Sebag-Montefiore was the last independent director to join the board, commencing their role in 2014. The company's minority of independent directors is a risk according to the Simply Wall St Risk Model. Reported Earnings • Nov 25
First half 2022 earnings: Revenues and EPS in line with analyst expectations First half 2022 results: EPS: UK£0.01 (up from UK£0.012 loss in 1H 2021). Revenue: UK£4.20m (up 35% from 1H 2021). Net income: UK£135.0k (up UK£293.0k from 1H 2021). Profit margin: 3.2% (up from net loss in 1H 2021). The move to profitability was driven by higher revenue. Revenue was in line with analyst estimates. Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 56 percentage points per year, which is a significant difference in performance. Reported Earnings • Sep 28
Full year 2021 earnings released: UK£0.032 loss per share (vs UK£0.019 loss in FY 2020) The company reported a poor full year result with increased losses, weaker revenues and weaker control over costs. Full year 2021 results: Revenue: UK£6.03m (down 17% from FY 2020). Net loss: UK£437.0k (loss widened 73% from FY 2020). Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 80 percentage points per year, which is a significant difference in performance. Reported Earnings • Aug 27
Full year 2021 earnings released: UK£0.032 loss per share (vs UK£0.019 loss in FY 2020) The company reported a poor full year result with increased losses, weaker revenues and weaker control over costs. Full year 2021 results: Revenue: UK£6.03m (down 17% from FY 2020). Net loss: UK£437.0k (loss widened 73% from FY 2020). Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 79 percentage points per year, which is a significant difference in performance. Is New 90 Day High Low • Mar 11
New 90-day low: UK£0.34 The company is down 7.0% from its price of UK£0.36 on 10 December 2020. The British market is up 4.0% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Specialty Retail industry, which is up 9.0% over the same period. Is New 90 Day High Low • Dec 02
New 90-day high: UK£0.36 The company is up 11% from its price of UK£0.33 on 03 September 2020. The British market is up 8.0% over the last 90 days, indicating the company outperformed over that time. However, it underperformed the Specialty Retail industry, which is up 14% over the same period. Reported Earnings • Nov 29
First half 2021 earnings released: UK£0.012 loss per share The company reported a poor first half result with weaker earnings, revenues and control over expenses. First half 2021 results: Revenue: UK£3.12m (down 14% from 1H 2020). Net loss: UK£158.0k (down 410% from profit in 1H 2020). Over the last 3 years on average, earnings per share has fallen by 103% per year but the company’s share price has only fallen by 16% per year, which means it has not declined as severely as earnings. お知らせ • Jul 23
Scholium Group Plc Does Not Propose to Declare Final Dividend for the Financial Year Ended 31 March 2020 Scholium Group Plc announced that the board does not propose to declare a final dividend for the financial year ended 31 March 2020.